Jump to Navigation
Quantitative
Research
Quantitative Models
Methodology Graphic
EQR White Paper
Investment
Products
Sabrient QES Energy Index
Baker's Dozen Model Portfolio
UITs
ETFs
Investor
Tools
Scorecards
Earnings Busters
Sector Detector
Advisors &
Individual Investors
Go to Investors Site
About Us
Our Company
Our People
ADV2A
Contact Us
Search form
Search
You are here:
You are here
Home
Gilead targets $1B Yeztugo sales in 2026 while raising base business outlook to $29.4B-$29.8B
Seeking Alpha
-
Fri, 05/08/2026 - 00:02
HubSpot: Risks Mounting, But Valuation Is Too Cheap To Ignore
Seeking Alpha
-
Fri, 05/08/2026 - 00:02
Sprout Social, Inc. 2026 Q1 - Results - Earnings Call Presentation
Seeking Alpha
-
Fri, 05/08/2026 - 00:02
Ormat Technologies, Inc. 2026 Q1 - Results - Earnings Call Presentation
Seeking Alpha
-
Fri, 05/08/2026 - 00:01
Which Railroad Belongs In Your Dividend Portfolio?
Seeking Alpha
-
Fri, 05/08/2026 - 00:00
Goldman Sachs BDC Non-GAAP NII of $0.22 misses by $0.08, TII of $78.8M misses by $4.98M
Seeking Alpha
-
Thu, 05/07/2026 - 23:58
GoodRx raises 2026 outlook to $765M-$785M revenue and at least $235M adjusted EBITDA, led by Pharma Direct
Seeking Alpha
-
Thu, 05/07/2026 - 23:54
Open Lending targets 100,000 to 110,000 certified loans in 2026 while projecting $25M to $29M adjusted EBITDA
Seeking Alpha
-
Thu, 05/07/2026 - 23:52
Amneal Pharmaceuticals beats top-line and bottom-line estimates; reaffirms FY26 outlook
Seeking Alpha
-
Thu, 05/07/2026 - 23:51
Teradyne: Market Command And Heavy Demand
Seeking Alpha
-
Thu, 05/07/2026 - 23:51
Western Asset GSM 5-Year Portfolios Q1 2026 Commentary
Seeking Alpha
-
Thu, 05/07/2026 - 23:45
LightPath outlines $6M CapEx plan while targeting gross margin move toward 40% amid capacity expansion
Seeking Alpha
-
Thu, 05/07/2026 - 23:42
Scorpio Tankers prices $150M reopening of 1.75% convertible notes due 2031, launches share repurchase
Seeking Alpha
-
Thu, 05/07/2026 - 23:40
Commerce.com: Not Out Of The Woods Yet With Weak Growth, High Churn
Seeking Alpha
-
Thu, 05/07/2026 - 23:39
Palvella targets 2H 2026 NDA filing while outlining >$1B peak U.S. sales potential for QTORIN rapamycin in microcystic lymphatic malformations
Seeking Alpha
-
Thu, 05/07/2026 - 23:32
Arcturus outlines 12-week ARCT-032 Phase II enrollment and extends cash runway beyond Q2 2028
Seeking Alpha
-
Thu, 05/07/2026 - 23:32
Axcelis Technologies, Inc. 2026 Q1 - Results - Earnings Call Presentation
Seeking Alpha
-
Thu, 05/07/2026 - 23:31
Gold Monthly: Rebounding After A Violent Drawdown
Seeking Alpha
-
Thu, 05/07/2026 - 23:30
Better projects $1.65B Q2 funded loan volume while targeting adjusted EBITDA breakeven by end of Q3 2026
Seeking Alpha
-
Thu, 05/07/2026 - 23:22
Expedia projects Q2 gross bookings growth of 7% to 9% amid reiterated full-year margin expansion of 100 to 125 bps
Seeking Alpha
-
Thu, 05/07/2026 - 23:22
Pages
« first
‹ previous
…
525
526
527
528
529
530
531
532
533
…
next ›
last »